These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22179404)

  • 1. Blockade of NKG2D synergized with CTLA4-Ig in promoting long-term graft survival in murine models of cardiac transplantation.
    Li J; Zhu H; Wang S; Ye P; Liu C; Wu J; Xia J
    Transplantation; 2012 Feb; 93(4):356-63. PubMed ID: 22179404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKG2D blockade attenuated cardiac allograft vasculopathy in a mouse model of cardiac transplantation.
    Chen H; Xia J; Zhang L; Jin X; Yang M; Li J; Zhao Y
    Clin Exp Immunol; 2013 Sep; 173(3):544-52. PubMed ID: 23638995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKG2D blockade significantly attenuates ischemia-reperfusion injury in a cardiac transplantation model.
    Shen B; Li J; Yang B
    Transplant Proc; 2013; 45(6):2513-6. PubMed ID: 23953572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. γδ T cell receptor deficiency attenuated cardiac allograft vasculopathy and promoted regulatory T cell expansion.
    Zhu H; Li J; Wang S; Liu K; Wang L; Huang L
    Scand J Immunol; 2013 Jul; 78(1):44-9. PubMed ID: 23659436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
    Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
    J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
    Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH
    J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation tolerance induced by CTLA4-Ig.
    Pearson TC; Alexander DZ; Winn KJ; Linsley PS; Lowry RP; Larsen CP
    Transplantation; 1994 Jun; 57(12):1701-6. PubMed ID: 8016872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion.
    Itoh S; Kimura N; Axtell RC; Velotta JB; Gong Y; Wang X; Kajiwara N; Nambu A; Shimura E; Adachi H; Iwakura Y; Saito H; Okumura K; Sudo K; Steinman L; Robbins RC; Nakae S; Fischbein MP
    Circulation; 2011 Sep; 124(11 Suppl):S187-96. PubMed ID: 21911812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.
    Pearson TC; Alexander DZ; Hendrix R; Elwood ET; Linsley PS; Winn KJ; Larsen CP
    Transplantation; 1996 Apr; 61(7):997-1004. PubMed ID: 8623206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway.
    Kosuge H; Suzuki J; Gotoh R; Koga N; Ito H; Isobe M; Inobe M; Uede T
    Transplantation; 2003 Apr; 75(8):1374-9. PubMed ID: 12717233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of γδ T cell-derived IL-17 in acute cardiac allograft rejection.
    Kimura N; Nakae S; Itoh S; Merk DR; Wang X; Gong Y; Okamura H; Chang PA; Adachi H; Robbins RC; Fischbein MP
    Ann Thorac Surg; 2012 Aug; 94(2):542-8. PubMed ID: 22560321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival.
    Lei J; He F; Wu M; Zheng X; Chen X; Chen Z
    Transpl Int; 2010 Dec; 23(12):1271-81. PubMed ID: 20646257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
    J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis.
    Wakita D; Sumida K; Iwakura Y; Nishikawa H; Ohkuri T; Chamoto K; Kitamura H; Nishimura T
    Eur J Immunol; 2010 Jul; 40(7):1927-37. PubMed ID: 20397212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of the activating NK cell receptor NKG2D accelerates rejection of cardiac allografts.
    Fabritius C; Ritschl PV; Resch T; Roth M; Ebner S; Günther J; Mellitzer V; Nguyen AV; Pratschke J; Sauter M; Klingel K; Kotsch K
    Am J Transplant; 2017 Dec; 17(12):3199-3209. PubMed ID: 28805342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the CTLA4 pathway in hyporesponsiveness induced by intratracheal delivery of alloantigen.
    Shirasugi N; Akiyama Y; Aramaki O; Shibutani S; Matsumoto K; Bashuda H; Yagita H; Okumura K; Ikeda Y; Niimi M
    Transplantation; 2003 May; 75(10):1636-9. PubMed ID: 12777848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance.
    Fan K; Wang H; Wei H; Zhou Q; Kou G; Hou S; Qian W; Dai J; Li B; Zhang Y; Zhu T; Guo Y
    Transplantation; 2007 Sep; 84(6):746-54. PubMed ID: 17893608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.